Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Onxeo S.A. buy melinda

Start price
€0.79
25.06.20 / 50%
Target price
€1.50
11.10.20
Performance (%)
-19.11%
End price
€0.64
11.10.20
Summary
This prediction ended on 11.10.20 with a price of €0.64. The price of Onxeo S.A. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.11%. melinda has 50% into this prediction

Onxeo is a cutting-edge biotechnology company that specializes in the research and development of novel drugs to treat patients with rare or resistant cancers. Headquartered in Paris, France, this innovative firm has established itself as a leader in the field by leveraging its advanced platform, known as DNA Therapeutics, in conjunction with a comprehensive portfolio of small molecules and orphan oncology assets. With a strong commitment to scientific excellence and a robust intellectual property strategy, Onxeo aims to improve patient outcomes by addressing critical unmet medical needs and creating value for stakeholders through strategic partnerships and licensing deals.

Performance without dividends (%)
Name 1w 1m 1y 3y
Onxeo S.A. -4.000% -4.000% -60.989% -84.206%
iShares Core DAX® -1.370% -3.231% 11.661% 16.545%
iShares Nasdaq 100 0.172% -3.339% 36.491% 43.334%
iShares Nikkei 225® -0.801% -7.859% 18.597% 4.253%
iShares S&P 500 -0.369% -2.979% 26.341% 40.911%

According to melinda what are the pros and cons of Onxeo S.A. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Onxeo S.A. diskutieren
Prediction Buy
Perf. (%) -19.11%
Target price 1.500
Change
Ends at 11.10.20

Buy mit Kursziel 1,5

In the thread Trading Onxeo S.A.
Prediction Buy
Perf. (%) -19.11%
Target price 1.500
Change
Ends at 11.10.20

Buy beendet

Stopped prediction by melinda for Onxeo S.A.

buy
Onxeo S.A.

Start price
Target price
Perf. (%)
€0.41
27.11.21
€0.60
27.11.22
-56.65%
28.11.22

Could be worthwhile Investment >10% per year
buy
Onxeo S.A.

Start price
Target price
Perf. (%)
€0.64
11.10.20
€0.80
04.11.21
-23.46%
05.11.21

Could be worthwhile Investment >10% per year
buy
Onxeo S.A.

Start price
Target price
Perf. (%)
€1.92
28.01.18
€2.30
30.07.18
-34.43%
30.07.18

Could be worthwhile Investment >10% per year
buy
Onxeo S.A.

Start price
Target price
Perf. (%)
€2.66
22.06.16
€3.50
05.07.16
37.22%
05.07.16

Could be worthwhile Investment >10% per year
buy
Onxeo S.A.

Start price
Target price
Perf. (%)
€7.03
31.10.14
€7.50
30.04.15
-19.06%
30.04.15

Could be worthwhile Investment >10% per year
buy
Onxeo S.A.

Start price
Target price
Perf. (%)
€5.69
14.12.10
€6.40
23.12.10
-2.64%
23.12.10

Could be worthwhile Investment >10% per year